Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

Zsofia Kote-Jarai, Ali Amin Al Olama, Graham G. Giles, Gianluca Severi, Johanna Schleutker, Maren Weischer, Daniele Campa, Elio Riboli, Tim Key, Henrik Gronberg, David J. Hunter, Peter Kraft, Michael J. Thun, Sue Ingles, Stephen Chanock, Demetrius Albanes, Richard B. Hayes, David E. Neal, Freddie C. Hamdy, Jenny L. DonovanPaul Pharoah, Fredrick Schumacher, Brian E. Henderson, Janet L. Stanford, Elaine A. Ostrander, Karina Dalsgaard Sorensen, Thilo Dörk, Gerald Andriole, Joanne L. Dickinson, Cezary Cybulski, Jan Lubinski, Amanda Spurdle, Judith A. Clements, Suzanne Chambers, Joanne Aitken, R. A.Frank Gardiner, Stephen N. Thibodeau, Dan Schaid, Esther M. John, Christiane Maier, Walther Vogel, Kathleen A. Cooney, Jong Y. Park, Lisa Cannon-Albright, Hermann Brenner, Tomonori Habuchi, Hong Wei Zhang, Yong Jie Lu, Radka Kaneva, Ken Muir, Sara Benlloch, Daniel A. Leongamornlert, Edward J. Saunders, Malgorzata Tymrakiewicz, Nadiya Mahmud, Michelle Guy, Lynne T. O'Brien, Rosemary A. Wilkinson, Amanda L. Hall, Emma J. Sawyer, Tokhir Dadaev, Jonathan Morrison, David P. Dearnaley, Alan Horwich, Robert A. Huddart, Vincent S. Khoo, Christopher C. Parker, Nicholas Van As, Christopher J. Woodhouse, Alan Thompson, Tim Christmas, Chris Ogden, Colin S. Cooper, Aritaya Lophatonanon, Melissa C. Southey, John L. Hopper, Dallas R. English, Tiina Wahlfors, Teuvo L.J. Tammela, Peter Klarskov, Børge G. Nordestgaard, M. Andreas Røder, Anne Tybjarg-Hansen, Stig E. Bojesen, Ruth Travis, Federico Canzian, Rudolf Kaaks, Fredrik Wiklund, Markus Aly, Sara Lindstrom, W. Ryan Diver, Susan Gapstur, Mariana C. Stern, Roman Corral, Jarmo Virtamo, Angela Cox, Christopher A. Haiman, Loic Le Marchand, Liesel Fitzgerald, Suzanne Kolb, Erika M. Kwon, Danielle M. Karyadi, Torben Falck Ørntoft, Michael Borre, Andreas Meyer, Jürgen Serth, Meredith Yeager, Sonja I. Berndt, James R. Marthick, Briony Patterson, Dominika Wokolorczyk, Jyotsna Batra, Felicity Lose, Shannon K. McDonnell, Amit D. Joshi, Ahva Shahabi, Antje E. Rinckleb, Ana Ray, Thomas A. Sellers, Hui Yi Lin, Robert A. Stephenson, James Farnham, Heiko Muller, Dietrich Rothenbacher, Norihiko Tsuchiya, Shintaro Narita, Guang Wen Cao, Chavdar Slavov, Vanio Mitev, Douglas F. Easton, Rosalind A. Eeles

Research output: Contribution to journalArticlepeer-review

248 Scopus citations


Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We conducted a multi-stage genome-wide association study for PrCa and previously reported the results of the first two stages, which identified 16 PrCa susceptibility loci. We report here the results of stage 3, in which we evaluated 1,536 SNPs in 4,574 individuals with prostate cancer (cases) and 4,164 controls. We followed up ten new association signals through genotyping in 51,311 samples in 30 studies from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. In addition to replicating previously reported loci, we identified seven new prostate cancer susceptibility loci on chromosomes 2p11, 3q23, 3q26, 5p12, 6p21, 12q13 and Xq12 (P = 4.0 × 10-8 to P = 2.7 × 10-24). We also identified a SNP in TERT more strongly associated with PrCa than that previously reported. More than 40 PrCa susceptibility loci, explaining 425% of the familial risk in this disease, have now been identified.

Original languageEnglish
Pages (from-to)785-791
Number of pages7
JournalNature Genetics
Issue number8
StatePublished - Aug 2011


Dive into the research topics of 'Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study'. Together they form a unique fingerprint.

Cite this